Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

In vitro reconstituted human erythrocyte, its preparation and application in blood substitute material

A human erythrocyte and erythrocyte technology, applied in animal cells, vertebrate cells, blood/immune system cells, etc., can solve the problems of fragile membranes, incalculable demand and market, difficult storage and transportation of natural blood, etc. Effect

Inactive Publication Date: 2003-04-16
FEIXIANG BIOTECH CHONGQING
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

There are a series of problems in traditional personnel blood transfusion methods: 1. Natural blood storage and transportation are also very difficult: the storage time of blood is short, and the longest storage time is 42 days at 4°C-8°C, and it is easy to cause hemolysis if it is transported for a long distance
2. Due to the risk of various viruses including AIDS and hepatitis, although blood donors have undergone strict blood test screening, the risk of hepatitis C is still 1:3000, and the risk of HIV infection is 1:100000~1:1000000 ; Blood transfusions can also cause the transmission of other viruses, bacteria, parasites, and other diseases
3. Donor-recipient matching is required for blood transfusion, otherwise there will be immune reactions, compatibility of different blood types, lack of special blood types, etc.
4. Population aging, lack of healthy blood supply population, serious shortage of fresh blood in some areas, serious shortage of blood sources, etc., bring serious difficulties and challenges to clinical treatment and first aid; especially in wars, severe natural disasters, terrorist In emergencies, it is difficult to meet the actual demand only by blood supply from blood banks and personnel donations. Therefore, the demand market for blood substitutes, especially "reconstructed red blood cells" that is closest to normal red blood cells in terms of performance and function, is incalculable.
But its existing problems are: the oxygen-carrying efficiency of this kind of liposome artificial red blood cells is not high, the membrane is brittle, hemoglobin leaks, and the storage time is as short as ten minutes, and the longest is only a few days
The reason why the stability and oxygen-carrying function of liposome-encapsulated hemoglobin cannot meet the requirements is that previous studies have ignored the structural relationship between hemoglobin and structural proteins, and between structural proteins and membrane lipids, and the impact of this relationship on red blood cells. Contributes to excellent deformability and rheological properties while only physically encapsulating hemoglobin with membrane lipids

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • In vitro reconstituted human erythrocyte, its preparation and application in blood substitute material
  • In vitro reconstituted human erythrocyte, its preparation and application in blood substitute material
  • In vitro reconstituted human erythrocyte, its preparation and application in blood substitute material

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 2

[0031] The structural protein crude product is obtained through dialysis, desalting, purification and freeze-drying to obtain the structural protein product. The plant structural proteins obtained by this method are globulins, usually αβ dimers, tetramers, and hexamers. In the experiment, more than 70% of the products are αβ dimer globulins through the regulation of pH and ionic strength. Example 2 Separation and Purification Method II of Structural Protein

[0032] (1), extract structural protein

[0033] Use animal blood containing anticoagulants (per 30ml of blood plus about 5ml of heparin pH7.4 isotonic phosphate buffer) In order to minimize the denaturation and enzymatic hydrolysis of structural proteins, the entire operation should be performed at a low temperature of 0-4°C conduct. Take 5ml of the above-mentioned anticoagulated blood, refrigerated and centrifuged (3000rpm, ~4°C, 15-30 minutes) to precipitate red blood cells, and separate the plasma supernatant and buf...

Embodiment 5

[0038] The structural protein product obtained by separation and purification is dissolved in physiological saline at a concentration of 200-800 ppm, and subjected to ultraviolet spectrophotometric analysis. Instrument: PE-λ900, scanning wavelength range: 200-400nm. For spectrogram see figure 2 . The solid lines in the figure represent the ultraviolet absorption peaks of structural proteins derived from animal blood, and the dotted lines represent the ultraviolet absorption peaks of structural proteins derived from plant proteins. The three spectral curves all show the maximum absorption peak at 280nm. Example 3 Structural Protein Gel Electrophoresis UV Scanning Spectrum Detection

Embodiment 3

[0038] The structural protein product obtained by separation and purification is dissolved in physiological saline at a concentration of 200-800 ppm, and subjected to ultraviolet spectrophotometric analysis. Instrument: PE-λ900, scanning wavelength range: 200-400nm. For spectrogram see figure 2 . The solid lines in the figure represent the ultraviolet absorption peaks of structural proteins derived from animal blood, and the dotted lines represent the ultraviolet absorption peaks of structural proteins derived from plant proteins. The three spectral curves all show the maximum absorption peak at 280nm. Example 3 Structural Protein Gel Electrophoresis UV Scanning Spectrum Detection

[0039] The structural protein product obtained by separation and purification is dissolved in physiological saline at a concentration of 10-200 μg / ml, and analyzed by polyacrylamide gel electrophoresis. Instrument: electrophoresis instrument BIO-RAD300; image system: IMAGE SYSTEM SX-100 scanni...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

A human red cell recombined in vitro, its preparing process and it application to blood substitute are disclosed. The said human red cell is composed of haematoglobin, structural protein and phospholipid and has the physiological function and form, which are similar to that of natural red cell. Its advantages are good deformability, good stability, strong oxygen carrying and releasing power, and controllable size.

Description

technical field [0001] The invention relates to an artificial red blood cell reconstructed in vitro by structural protein, phospholipid, hemoglobin, etc., as a new blood substitute. The present invention uses structural protein and phospholipid as the basic molecular materials to synergistically encapsulate hemoglobin to reconstruct artificial red blood cells in vitro; through the combination of hemoglobin, structural protein and phospholipid, the physiological function and shape of the reconstructed in vitro are close to natural red blood cells, with deformability and stability Good, strong oxygen-carrying-oxygen-releasing capacity, deimmunized, and the cell size can be controlled to the nanometer scale to rebuild red blood cells. The present invention also relates to the preparation method of the reconstituted red blood cells and its application in blood substitutes. Background technique: [0002] So far, the blood substitutes used in medicine can only simulate the normal...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/078
Inventor 王翔段建军高玮
Owner FEIXIANG BIOTECH CHONGQING
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com